A conference call is scheduled for Wednesday to discuss quarterly numbers and the status of the trial. It looks like the trial was completed a month or so ago, and it is hard to imagine that the Company does not know how it went. Frankly, I tend to think that Roth and Oppenheimer have been privy to "unofficial" information as well.
I am very long the stock, so perhaps this is just wishful thinking. But it is not so long ago that the stock was trading at $9, and, if anything, the story has gotten better.
It will be interesting to see what happens on Monday.
CNAT 3.75 - moving back into the strike zone? I don't know - Book-Value now at less than $1 and they still have a burnrate of approx. -$.15 per quarter. From their website, the next catalyst not coming until 2H18:
News 
Market Data 
Discover 
